Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=imgnLatest Financial News for ImmunoGen, Inc.en-usThu, 17 Dec 2009 21:01:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217005713.html?.v=1WALTHAM, Mass.----ImmunoGen, Inc. , a biotechnology company that develops targeted anticancer products, announced today the appointment of Suzanne Cadden as Vice President of Regulatory Affairs & Quality.yahoo_finance/3357693709Thu, 17 Dec 2009 21:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11hd3g7f9/*http%3A//www.cnbc.com/id/34449772/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/435397123Wed, 16 Dec 2009 23:58:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh68638_2009-12-14_10-46-36_lde5bd044_newsml&rpc=44&type=marketsNewsyahoo_finance/4229325776Mon, 14 Dec 2009 10:46:36 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13ckpf5bm/*http%3A//www.thestreet.com/_yahoo/story/10644637/1/roche-immunogen-to-start-new-t-dm1-clinical-trials.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3603262660Mon, 14 Dec 2009 05:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12v0m93a9/*http%3A//www.thestreet.com/_yahoo/story/10644637/1/roche-immunogen-to-start-t-dm1-trials.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1524306877Mon, 14 Dec 2009 05:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091212/20091212005008.html?.v=1WALTHAM, Mass.----ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of positive trastuzumab-DM1 clinical data at the 32nd Annual San Antonio Breast Cancer Symposium .yahoo_finance/3723563288Sat, 12 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11hqmfe2m/*http%3A//www.cnbc.com/id/34381947/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/863759717Sat, 12 Dec 2009 01:56:17 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12sflu910/*http%3A//www.thestreet.com/_yahoo/story/10642486/1/jim-cramers-portfolios-of-the-week.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1271570863Fri, 11 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1315jslb6/*http%3A//www.thestreet.com/_yahoo/story/10643058/1/biotech-stock-mailbag-cell-therapeutics.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/44584048Fri, 11 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12mkn1hn4/*http%3A//www.fool.com/investing/general/2009/12/10/4-star-stocks-on-the-upswing.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3125681141Thu, 10 Dec 2009 19:45:41 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091209/us_immunogen_study.html?.v=2Immunogen Inc. said Wednesday its developing cancer treatment T-DM1 prompted a 32.7 percent response rate in a midstage study on breast cancer patients, pushing shares higher.yahoo_finance/2707245339Wed, 9 Dec 2009 21:50:33 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12nvb10cb/*http%3A//www.thestreet.com/_yahoo/story/10642257/1/immunogen-posts-t-dm1-results.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/968603550Wed, 9 Dec 2009 18:34:18 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091209/imgn8-k.htmlyahoo_finance/3476770230Wed, 9 Dec 2009 18:05:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091207/20091207006076.html?.v=1WALTHAM, Mass.----ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of encouraging initial clinical findings with SAR3419 at the American Society of Hematology 51st Annual Meeting and Exposition.yahoo_finance/3628974966Mon, 7 Dec 2009 21:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=127cg769c/*http%3A//boston.bizjournals.com/boston/stories/2009/12/07/daily3.html?ana=yfcpcyahoo_finance/2752212891Mon, 7 Dec 2009 16:05:22 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091207/imgn8-k.htmlyahoo_finance/3982367696Mon, 7 Dec 2009 13:35:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091206/20091206005066.html?.v=1WALTHAM, Mass.----ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma , including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.yahoo_finance/1107143370Mon, 7 Dec 2009 00:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=14124h1cl/*http%3A//www.thestreet.com/_yahoo/story/10639063/1/cramers-mad-money-recap-how-to-play-the-surprising-jobs-report-update-1.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1555932698Fri, 4 Dec 2009 23:39:12 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11hpftt9h/*http%3A//www.cnbc.com/id/34280189/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/1063390154Fri, 4 Dec 2009 23:21:04 Etc/GMThttp://us.rd.yahoo.com/finance/external/video/cnbc/rss/SIG=113mb0hsu/*http%3A//www.cnbc.com/id/15840232?play=1&video=1350440413&__source=yahoo%7Cheadline%7Cquote%7Cvideo%7C&par=yahooyahoo_finance/3210132210Fri, 4 Dec 2009 23:00:00 Etc/GMT